NDC 17856-1122-7 - MAX relief junior Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1122
- Requested NDC
- 17856-1122-7
- Package NDCs from labels
- 17856-1122-5, 17856-1122-1, 17856-1122-8, 17856-1122-4, 17856-1122-6, 17856-1122-2, 17856-1122-7, 17856-1122-3, 17856-1122-9
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior Grape - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-02-13 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1122-1 | MAX relief junior Grape | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 4 | |
| 17856-1122-2 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-3 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-4 | MAX relief junior Grape | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 4 | |
| 17856-1122-5 | MAX relief junior Grape | 20.3 mL in 1 CUP, UNIT-DOSE | LIQUID | 20.3 | 4 | |
| 17856-1122-6 | MAX relief junior Grape | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 4 | |
| 17856-1122-7 | MAX relief junior Grape | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 4 | |
| 17856-1122-8 | MAX relief junior Grape | 15 mL in 1 CUP, UNIT-DOSE | LIQUID | 15 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 60 in 1 BOX, UNIT-DOSE | LIQUID | 60 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 1 mL in 1 SYRINGE | LIQUID | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1122 | MAX RELIEF JUNIOR GRAPE (CHILDRENS ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 10 package rows | 20250514_562d7901-44d6-4d9b-be8b-a8d468a22c43.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1122-1 | ML - Milliliter | 17856-1122 | 6ff0a9b2-03be-4ea1-8611-39fbd5be4f4b | 1 | 2026-02-05 |
| 17856-1122-5 | ML - Milliliter | 17856-1122 | 8df3891c-73a2-47c4-bcee-72eea1317e38 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pranicura 5 | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Pranicura Products LLC | af520a58-3f3c-4d28-a41f-3ed8f74da095 | 2025-11-04 | Warnings | PDC6A3C0OX |
| Children Pain and Fever Reliver | ACETAMINOPHEN | Target Corporation | 1116f808-f61e-47ec-b0d0-d4be5aa905be | 2025-11-04 | Warnings | M013 362O9ITL9D |
| Pain Reliever Dye Free | ACETAMINOPHEN | TIME CAP LABORATORIES, INC. | 42c4f0b2-6483-0f3c-e063-6294a90a140f | 2025-11-04 | Warnings | M013 362O9ITL9D |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walmart Inc. | 1557bd9b-3e7c-4769-e063-6394a90a9d91 | 2025-11-04 | Warnings | M013 362O9ITL9D |
| Adult Low Dose Aspirin | ASPIRIN | Rising Pharma Holdings, Inc. | c3c4854e-726e-4926-b044-a5094943c306 | 2025-11-04 | Warnings | M013 |
| QUALITY CHOICE Maximum Strength Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | Chain Drug Marketing Association, Inc. | 40413cdb-68ac-70e1-e063-6394a90a9217 | 2025-11-04 | Warnings | 362O9ITL9D |
| Cold plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e618bc7-0f51-e586-e063-6294a90afe37 | 2025-11-03 | Warnings | 362O9ITL9D |
| Head Congestion plus Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e61b5b3-ad15-01bf-e063-6394a90a6ec3 | 2025-11-03 | Warnings | 362O9ITL9D |
| Cold plus Head Congestion Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 409540c0-1bab-9969-e063-6394a90a47c1 | 2025-11-03 | Warnings | 362O9ITL9D |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e60b340-bd60-9318-e063-6294a90ad079 | 2025-11-03 | Warnings | 362O9ITL9D |
| Sinus Pressure and Pain PE | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e60e32f-3e5f-b775-e063-6294a90a097d | 2025-11-03 | Warnings | 362O9ITL9D |
| Sinus and Headache | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e614265-b35a-5d01-e063-6294a90aad85 | 2025-11-03 | Warnings | 362O9ITL9D |
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 3e50b3f6-1e1a-41b9-e063-6394a90abe36 | 2025-11-03 | Warnings | M013 362O9ITL9D |
| Good Sense Pain Relief | ACETAMINOPHEN | L. Perrigo Company | 447de441-7d28-4415-81c5-4fc05622dd05 | 2025-11-03 | Warnings | M013 362O9ITL9D |
| Children Acetaminophen Oral Solution | ACETAMINOPHEN | VERITYRX. LLC | 42a17f54-7851-84fb-e063-6394a90a9ec1 | 2025-11-02 | Warnings | M013 307675 362O9ITL9D |
| M-PAP | ACETAMINOPHEN | VERITYRX, LLC | 42a1a128-a2dd-bbc9-e063-6294a90a4fe1 | 2025-11-02 | Warnings | M013 307675 362O9ITL9D |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Severe Sinus Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE | Shield Pharmaceuticals Corp | c296efd0-5030-4a26-a9b0-e66423d995dc | 2025-10-31 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.